Fluidnatek made a significant impact at Medical Technology Ireland 2025, held September 24–25 at the Galway Racecourse, where we proudly unveiled our groundbreaking LE-50 Gen2 electrospinning and electrospraying platform. This cutting-edge system represents the future of nanofiber and nanoparticle research in biomedical applications.
Live Innovation in Action
Our exhibition stand became a hub of scientific discovery as attendees witnessed live demonstrations of the LE-50 Gen2‘s remarkable capabilities. This state-of-the-art benchtop system revolutionizes laboratory research by seamlessly integrating both needle-based and needleless technologies within a single, versatile unit.
Key breakthrough features include:
- Dual-solution processing capabilities
- Independent high-voltage control systems
- Automated emitter motion ensuring exceptional homogeneity
- Unmatched precision for multi-material scaffold development
These advanced functionalities position the LE-50 Gen2 as the ideal solution for pioneering applications in tissue engineering, accelerated wound healing, precision drug delivery systems, and next-generation medical device coatings.
Expert Representation
Fluidnatek’s presence was expertly represented by our specialized team:
- Enrique Navarro, Sales & Marketing Manager
- Milan Proks, Key Account Manager
Transforming Medical Science
Electrospinning technology is revolutionizing biomedical research by enabling the creation of nanofiber-based scaffolds that precisely replicate the natural extracellular matrix. This biomimetic approach significantly enhances cell growth and accelerates tissue regeneration processes. Additionally, our electrospun materials deliver controlled, targeted release of therapeutic compounds, opening new frontiers in personalized medicine.
The LE-50 Gen2’s exceptional precision combined with its scalability makes it an indispensable tool for researchers and companies driving the next wave of medical technology breakthroughs.
Looking Forward
We extend our sincere gratitude to all the innovators, researchers, and industry leaders who visited our stand and engaged in meaningful discussions about how Fluidnatek’s advanced solutions can accelerate biomedical innovation. These valuable conversations fuel our commitment to pushing the boundaries of what’s possible in medical technology.
For more information about the LE-50 Gen2 and how it can transform your biomedical research, contact our team today.
Live demonstrations of the LE50 Gen2.
ESP